NCT06794645 2025-01-27Pembrolizumab and Pemetrexed for Progressive ChordomaSaint John's Cancer InstitutePhase 2 Recruiting21 enrolled
NCT03955042 2023-03-07Pemetrexed for the Treatment of ChordomaSaint John's Cancer InstitutePhase 1 Completed15 enrolled